Polatuzumab
Modify Date: 2025-08-25 18:50:45
Polatuzumab structure
|
Common Name | Polatuzumab | ||
|---|---|---|---|---|
| CAS Number | 2279068-37-8 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of PolatuzumabPolatuzumab is a monoclonal antibody, which targets CD79b that is found on the surface of B cells. Polatuzumab sticks to the CD79b protein and delivers the chemotherapy compound into the cell. Polatuzumab can be used to synthesize Polatuzumab Vedotin, which is an antibody-drug conjugate (ADC) targeting CD79b [1]. |
| Name | Polatuzumab |
|---|
| Description | Polatuzumab is a monoclonal antibody, which targets CD79b that is found on the surface of B cells. Polatuzumab sticks to the CD79b protein and delivers the chemotherapy compound into the cell. Polatuzumab can be used to synthesize Polatuzumab Vedotin, which is an antibody-drug conjugate (ADC) targeting CD79b [1]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |